Israel Englander Enochian Biosciences Inc Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Millennium Management LLC holds 293,631 shares of ENOB stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

293,631

Previous 126,314 132.46%

Holding current value

$1.35 Million

Previous $581,000 132.36%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	167,317 Added 132.46%	293,631 $1.35 Million
Q4 2023 Feb 14, 2024	SELL	$4.3 - $4.7 $538,205 - $588,270	-125,164 Reduced 49.77%	126,314 $581,000
Q2 2023 Aug 14, 2023	BUY	$0.4 - $1.3 $85,881 - $279,115	214,704 Added 583.85%	251,478 $143,000
Q1 2023 May 15, 2023	SELL	$0.91 - $1.31 $14,596 - $21,012	-16,040 Reduced 30.37%	36,774 $34,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.13 $20,219 - $41,814	19,631 Added 59.16%	52,814 $54,000

Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.86 $69,701 - $117,262	-41,001 Reduced 55.27%	33,183 $60,000
Q2 2022 Aug 15, 2022	SELL	$1.93 - $8.73 $217,372 - $983,242	-112,628 Reduced 60.29%	74,184 $143,000
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $540,610 - $1.1 Million	122,310 Added 189.62%	186,812 $1.54 Million
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $432,808 - $809,500	64,502 New	64,502 $470,000
Q3 2021 Nov 15, 2021	SELL	$4.56 - $7.88 $531,996 - $919,328	-116,666 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.94 - $6.79 $342,998 - $792,162	116,666 New	116,666 $580,000
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $101,957 - $128,350	-36,155 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.42 - $4.55 $123,650 - $164,505	36,155 New	36,155 $129,000
Q2 2020 Aug 14, 2020	SELL	$2.78 - $6.06 $30,421 - $66,314	-10,943 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.08 - $5.41 $22,761 - $59,201	10,943 New	10,943 $33,000
Q4 2019 Feb 14, 2020	SELL	$3.48 - $6.75 $95,995 - $186,198	-27,585 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.95 - $5.72 $202,828 - $293,716	-51,349 Reduced 65.05%	27,585 $151,000
Q2 2019 Aug 15, 2019	SELL	$4.5 - $6.99 $245,344 - $381,101	-54,521 Reduced 40.85%	78,934 $355,000
Q2 2019 Aug 14, 2019	BUY	$4.5 - $6.99 $255,964 - $397,598	56,881 Added 74.28%	133,455 $8.21 Million
Q1 2019 May 14, 2019	BUY	$5.82 - $9.25 $445,660 - $708,309	76,574 New	76,574 $531,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

7.25M

Call Options Held

16K

Put Options Held

12.5K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account